Accès à distance ? S'identifier sur le proxy UCLouvain
Cost effectiveness of Rivaroxaban versus low molecular weight heparin and vitamin K antagonists for the treatment of deep-vein thrombosis in the Belgian healthcare setting
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Publication date | 2015 |
Language | Anglais |
Journal information | "The European Journal of Cardiovascular Medicine" - Vol. 3, no. 1, p. 452-461 (2015) |
Publisher | Healthcare Bulletin ((United Kingdom) London) |
issn | 2042-4884 |
e-issn | 2042-4892 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC - Institut de recherche expérimentale et clinique UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI) |
Links |
Bibliographic reference | Maervoet, Johan ; Verhamme, Peter ; Hainaut, Philippe ; McLeod, Euan ; Bamber, Luke ; et. al. Cost effectiveness of Rivaroxaban versus low molecular weight heparin and vitamin K antagonists for the treatment of deep-vein thrombosis in the Belgian healthcare setting. In: The European Journal of Cardiovascular Medicine, Vol. 3, no. 1, p. 452-461 (2015) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/172115 |